Journal of the American Academy of Dermatology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study.
78:741-748.
2018
-
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study.
76:60-69.e9.
2017
-
Interleukin 17A: Toward a new understanding of psoriasis pathogenesis.
71:141-150.
2014
-
Stem cell transplantation in advanced cutaneous T-cell lymphoma.
58:645-649.
2008
-
Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy.
57:1-27.
2007
-
Clinicopathologic features and T-cell receptor gene rearrangement findings of mycosis fungoides palmaris et plantaris.
54:466-471.
2006
-
Classic Kaposi's sarcoma in the Inuit of northern Quebec.
52:S31-S34.
2005
-
Hiccups, eructation, and other uncommon prodromal manifestations of herpes zoster.
49:1121-1124.
2003
-
Ultraviolet autorepigmentation in scleroderma..
49:960-961.
2003
-
Prognostic factors for life expectancy in nonagenarians with nonmelanoma skin cancer: Implications for selecting surgical candidates.
47:419-422.
2002
-
Measuring quality of life in people referred for specialist care of acne: Comparing generic and disease-specific measures.
43:229-233.
2000
-
Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides.
43:54-60.
2000
-
Detection of artificial changes in mole size by skin self-examination.
42:754-759.
2000
-
Topical calcipotriol in childhood psoriasis.
36:203-208.
1997
-
A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff.
29:1008-1012.
1993
-
Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
26:960-967.
1992
-
Actinic prurigo: Clinical features and prognosis.
26:683-692.
1992
-
Polymyositis: A manifestation of chronic graft-versus-host disease.
25:560-562.
1991
-
Langerhans cell histiocytosis in monozygotic twins.
24:32-37.
1991
-
HLA typing in actinic prurigo.
22:1019-1023.
1990
-
PRETIBIAL EPIDERMOLYSIS-BULLOSA - REPORT OF A CASE.
22:346-350.
1990
-
Pretibial epidermolysis bullosa: Report of a case.
22:346-350.
1990
-
Thyroid evaluation in alopecia areata in children.
19:1118-1118.
1988
-
Secukinumab demonstrates significant improvement of disease activity and health-related quality of life in Canadian psoriasis patients in a real-world setting
2018
-
Sociodemographic and baseline disease profile of patients with moderate to severe chronic plaque psoriasis treated with secukinumab vs. other treatments in Canadian routine clinical care: Results from the PURE registry
2018
-
Early real-world effectiveness of secukinumab in the treatment of psoriasis in Canada: Retrospective analysis of patient support program data
2017
-
Secukinumab provides greater 52-week sustained relief from dermatology-related quality of life impact on clothing choice and sexual function than ustekinumab
2017
-
Secukinumab provides greater cumulative 52-week skin clearance and quality of life benefit in patients with moderate-to-severe plaque psoriasis than ustekinumab: An area under the curve analysis
2017
-
Comparison of guselkumab with placebo and adalimumab on health-related quality of life in a phase 2b clinical trial X-PLORE
2016
-
Cutaneous disease is associated with higher early systemic lupus disease activity
2015
-
A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population
2013
-
A study of systemic scleroderma in the southern region of Brazil: Cutaneous manifestations and clinical and laboratory marker association
2009
-
Combining biologics and cyclosporine for psoriasis treatment
2009
-
Comparison of identical patch test allergens front different commercial sources in Brazil
2009
-
Cost analysis of system therapy for psoriasis in Brazil
2009
-
Efalizumab's effectiveness in treating plaque psoriasis affecting the hands/feet, scalp, and nails: Interim subanalysis of the Canadian RESTORE study data
2009
-
Immune reconstitution inflammatory syndrome surrounding molluscum contagiosum
2009
-
Physical and psychological assessment follow-up for moderate and severe psoriasis using acitretin
2009
-
Prevalence of metabolic syndrome among patients with psoriasis at a dermatologic service in the south of Brazil
2009
-
Two identical triplet sisters with different psoriasis presentation form and response to etanercept without genetic mutation at inflammatory cytokine gene promoters
2009
-
A practical understanding of mean percent PASI reduction for biologics
2008
-
Group for research and assessment of psoriasis and psoriatic arthritis-international multi-center psoriasis and psoriatic arthritis reliability trial (GRAPPA-IMPART): Assessment of psoriasis, nail lesions, peripheral arthritis, and dactylitis
2008
-
Infliximab-induced pustular psoriasis
2008
-
Palmoplantar keratoderma in a patient with a chromosome 12q deletion
2008
-
Similar responses with adalimumab therapy in patients with moderate versus severe psoriasis: Subanalysis of multiple placebo-controlled trials
2008
-
Clinical, histopathologic features, and T-cell receptor gene rearrangement findings of cutaneous T-cell lymphoma in children
2007
-
Erythema multiforme-like with topical diphenylcyclo-propenone
2006
-
Objective evaluation of wrinkle improvement in a cosmetic treatment using digital photography
2006
-
Classic Kaposi's sarcoma in the Inuit of northern Quebec
2005
-
Basal cell carcinoma of the nipple and areola: a case report and review of the literature
2004
-
Ecthyma gangrenosum
2004
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)